Aptargroup, Inc. Aktie News

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar to Present at Jefferies Global Healthcare Conference on November 19, 2025.

AptarGroup's shares have dropped over 25% from summer highs due to slower growth, especially in high-margin pharma emergency solutions. ATR's valuation has compressed from 26x to 20x earnings, reflecting concerns about flat growth and a soft outlook for 2026. Pharma remains the most profitable segment, but headwinds in emergency-use delivery systems are expected to impact revenues next year.

AptarGroup, Inc. ( ATR ) Q3 2025 Earnings Call October 31, 2025 9:00 AM EDT Company Participants Marry Skafidas - Senior Vice President of Investor Relations & Communications Stephan Tanda - President, CEO & Executive Director Vanessa Kanu - Executive VP & CFO Conference Call Participants Ghansham Panjabi - Robert W. Baird & Co. Incorporated, Research Division Paul Knight - KeyBanc Capital Mark...

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Third Quarter 2025 Results.

The London Company Mid Cap portfolio increased 1.5% gross (1.3% net) during the quarter vs. a 5.3% increase in the Russell Midcap Index. Both stock selection & sector exposure were headwinds to relative performance. We believe our strategy is well positioned for long-term investors seeking a more conservative approach to mid cap investing.

AptarGroup, Inc. (NYSE:ATR ) 2025 Investor Day Call Company Participants Marry Skafidas - Senior Vice President of Investor Relations & Communications Stephan Tanda - President, CEO & Executive Director Gael Touya - President of Aptar Pharma Alex Theodorakis Marc Prieur - President of Aptar Beauty Heidi Tlili - President of Aptar Closures Vanessa Kanu - Executive VP & CFO Conference Call Partic...

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Increases Quarterly Dividend by Nearly 7% Signaling Continued Momentum and Long-Term Strength.

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Announces 2025 Investor Day.